RYAN MOBLEY: Open Payments
NPI 1720022767 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,012 in 229 payments from 46 companies in 2025. Trend: 2023 $3,956 · 2024 $4,371 · 2025 $6,012
Food & beverage: $5,917Education: $95
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $708 |
| Daiichi Sankyo Inc. | 15 | $399 |
| PFIZER INC. | 16 | $351 |
| Janssen Biotech, Inc. | 13 | $308 |
| Merck Sharp & Dohme LLC | 10 | $295 |
| GlaxoSmithKline, LLC. | 11 | $274 |
| SOBI, INC | 5 | $272 |
| ABBVIE INC. | 14 | $247 |
| Novartis Pharmaceuticals Corporation | 10 | $228 |
| Incyte Corporation | 11 | $211 |
Products named: KEYTRUDA, Epkinly, OJJAARA, DATROWAY, INJECTAFER, JAKAFI, OPDIVO, Xtandi.
Industry payments across AZ — which companies pay providers there.
